The Role of Comorbidities in Cardioprotection
Author:
Affiliation:
1. Center for Molecular Medicine, NHLBI, NIH, Bethesda, MD, USA
2. Systems Biology Center, NHLBI, NIH, Bethesda, MD, USA Tish.Murphy@nih.hhs.gov
Abstract
Publisher
SAGE Publications
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology
Link
http://journals.sagepub.com/doi/pdf/10.1177/1074248411408313
Reference54 articles.
1. Myocardial Protection at a Crossroads
2. Why did the NHE inhibitor clinical trials fail?
3. Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study
4. Postconditioning and protection from reperfusion injury: where do we stand? * Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
5. The impairment of preconditioning-mediated cardioprotection in pathological conditions
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?;International Journal of Molecular Sciences;2023-01-06
2. Probiotic Therapy with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis;Microorganisms;2022-11-18
3. Comparative evaluation of infarct-limiting efficiency of postconditioning with lactate in ischemia-reperfusion of the myocardium in young and old rats and rats with transient hypercholesterolemia;Proceedings of the National Academy of Sciences of Belarus, Medical series;2022-06-08
4. Hypercholesterolemia attenuates cardioprotection of ischemic preconditioning and postconditioning with α7 nicotinic acetylcholine receptor agonist by enhancing inflammation and inhibiting the PI3K/Akt/eNOS pathway;Experimental and Therapeutic Medicine;2022-03-22
5. Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms;Cardiovascular Drugs and Therapy;2022-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3